StocksMedium•2 November 2026•
1 min read
Vertex Pharmaceuticals Q3 Earnings Miss Analyst Estimates
Key Facts
1Vertex Pharmaceuticals reported quarterly earnings of $4.76 per share, missing the Zacks Consensus Estimate of $4.92 per share.
Vertex Pharmaceuticals reported quarterly earnings of $4.76 per share for the third quarter of 2026. According to Zacks, the results missed the consensus estimate of $4.92 per share, as the company's financial performance fell short of analyst expectations for the period.
Vertex Pharmaceuticals, trading under the ticker VRTX, closed at $558.88 on October 30, 2026. During that session, the stock reached a high of $563.8 and a low of $549.89, preceding the announcement of the earnings miss which represented an approximately 3.2% deviation from anticipated figures.